A blood test to screen for Alzheimer's disease in India? The rollout could make earlier and less invasive detection more ...

This key milestone establishes CNSide Diagnostics as a Medicare-enrolled clinical laboratory, enabling the submission of claims for its CNSide ® Cerebrospinal Fluid (CSF) Assay Platform, including the ...

If you already use ISO 27001 or the NIST Cybersecurity Framework, you may be closer to NIS2 than you think. For many UK SMEs, the useful question is not whether the three frameworks are identical, but ...

Imagine a 62-year-old woman who aces every memory test her doctor gives her. Her brain scans look clean. She feels sharp. But ...

Purpose Biomarkers related to the diagnosis, prognosis and treatment of dementia will play a key role in future clinical practice. The overarching aim of the ODIN (blood and cerebrospinal fluid) ...

Mass General Brigham researchers developed a test to detect TDP-43 protein clumps linked to FTLD-TDP dementia. The biomarker ...

CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), announced today a new payer coverage agreement with Blue Shield of California, ...

Puma Biotechnology (NASDAQ:PBYI) reported first-quarter 2026 total revenue of $44.8 million, driven primarily by NERLYNX ...

Delve Bio, a UCSF spin-out and pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, announced data underscoring the clinical impact of mNGS using Delve Detect to identify ...

Researchers found the nerve damage biomarker NfL in menstrual fluid, meaning tampon-collected samples could help monitor ...

In a survey of nearly 600 adults seen in primary care, roughly 85% said they would agree to a blood-based Alzheimer’s test if ...